ロード中...
Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report
ALZET(®) osmotic pumps are implantable devices used in animals for the continuous infusion of drugs or proteins at controlled rates from 1 day to 4 weeks. Pumps have been used successfully in a number of studies on the effects of controlled delivery of a wide range of experimental agents, independen...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501414/ https://ncbi.nlm.nih.gov/pubmed/23170122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.639 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|